Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Amgen.com is the global corporate website of Amgen, the American biotechnology company. According to the site, Amgen was founded in 1980 and is headquartered in Thousand Oaks, California. It is one of the representative early companies that helped drive the industrialization of biotechnology. The website has a clear corporate focus: presenting the company’s history, mission and values, R&D priorities, therapeutic areas, news updates, investor relations, corporate responsibility, and career opportunities.
The site’s most important function is corporate information disclosure and brand communication. Users can learn how Amgen uses living cells to produce biologic medicines, as well as its presence in areas such as cardiovascular disease, obesity and related conditions, rare diseases, inflammation, and oncology. The website also provides news stories, press releases, leadership team information, corporate governance details, compliance policies, awards and recognition, and job opportunities. Its key narratives include AI-enabled clinical development, generative biology, human genetic data, and a highly reliable pharmaceutical manufacturing and supply chain.
The official website does not offer a unified pricing model. Amgen’s core products are prescription medicines and biologics, and their prices are typically determined by multiple factors, including the drug, indication, country or region, insurance reimbursement, hospital channels, patient assistance programs, and regulatory policies. As a result, the site is not suitable for direct price comparison or purchasing medicines. Patients still need to confirm availability and costs through doctors, hospitals, pharmacies, or local official channels.
The advantages are that the information is authoritative and well structured, offering a systematic view of a multinational innovative pharmaceutical company’s R&D capabilities, historical milestones, and governance framework. With global coverage in around 100 countries and regions, and an emphasis on supply reliability for “every patient, every time,” the site is especially valuable for investors, job seekers, and industry researchers. The downside is that the content leans toward corporate communication. Ordinary patients looking for specific information on medication use, pricing, reimbursement, and local approval status may still find it insufficient. In addition, the medical and drug development content is highly specialized and requires some background knowledge.
It is suitable for healthcare industry researchers, investors, pharmaceutical professionals, potential partners, job seekers, as well as patients and families who want to understand Amgen’s therapeutic areas and corporate developments. If the user’s goal is to make diagnosis or treatment decisions, the website should be used as a source of background information rather than a substitute for medical advice.
Based on its domain and content type, Amgen.com is a multinational corporate website and can generally be accessed directly. However, loading speed, video resources, and third-party scripts may vary by region. Users in China should also note that global information on the website is not equivalent to approval information in mainland China. Specific drug indications and availability should be verified against Chinese regulatory authorities and local official materials.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on amgen.com official site.
amgen.com is an United States Companies provider. TG4G tracks its product information, an overall rating of 8.0/10, and a China-accessibility score of China direct-connect friendly. Click "Visit Official Site" to reach amgen.com directly.